MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

12 Feb 2024 Evaluate
The sales slipped to Rs. 127.06 millions for the December 2023 quarter as against Rs. 134.20 millions during the year-ago period.The Total revenue for the quarter ended December 2023 of  Rs. 13.22  millions  grew by 721.12% from Rs. 1.61 millions.The company reported a good operating profit of 64.08 millions compared to 49.45 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 127.06 134.20 -5.32 333.30 372.21 -10.45 516.22 513.91 0.45
Other Income 0.30 0.09 233.33 0.30 0.16 87.50 0.36 0.92 -60.87
PBIDT 64.08 49.45 29.59 157.84 143.96 9.64 215.23 159.08 35.30
Interest 22.22 20.84 6.62 62.60 56.38 11.03 76.51 39.93 91.61
PBDT 41.86 28.61 46.31 95.24 87.58 8.75 138.72 119.15 16.42
Depreciation 22.76 23.03 -1.17 68.64 70.06 -2.03 92.66 74.41 24.53
PBT 19.10 5.58 242.29 26.60 17.52 51.83 46.06 44.74 2.95
TAX 5.88 3.97 48.11 8.36 11.57 -27.74 19.71 22.71 -13.21
Deferred Tax -0.09 3.02 -102.98 -1.11 8.64 -112.85 9.41 15.12 -37.76
PAT 13.22 1.61 721.12 18.24 5.95 206.55 26.35 22.03 19.61
Equity 149.04 148.77 0.18 149.04 148.77 0.18 149.03 142.64 4.48
PBIDTM(%) 50.43 36.85 36.87 47.36 38.68 22.44 41.69 30.95 34.69
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..